|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.61 HKD | -0.77% |
|
-10.14% | -10.76% |
| 04-29 | Abbisko Completes HK$523 Million Share Offering | MT |
| 04-23 | Abbisko Therapeutics Showcases Six Research Advances Highlighting Pan-KRAS, 4th Generation EGFR, And Synthetic Lethality Approaches | CI |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | -102.57x | 3.71x | 24.47x | -18.74x | -18.41x | 1.07B | ||
| -.--% | 0.13% | 27.67x | 5.45x | 7.31x | 21.83x | 22.41x | 49.1B | ||
| 1.68% | 1.89% | 17.68x | 3.41x | 5.41x | 11.83x | 13.64x | 47.65B | ||
| -.--% | -.--% | -18.13x | 1.06x | 3.57x | -6.5x | -5.02x | 23.8B | ||
| -.--% | -.--% | -37.65x | 58.75x | 12.57x | -34.1x | -39.81x | 21.97B | ||
| -.--% | -.--% | 21.42x | 2.11x | 4.23x | 10.98x | 13.21x | 17.26B | ||
| -.--% | -.--% | 23.19x | 2.43x | 4.36x | 13.78x | 16.16x | 15.88B | ||
| -.--% | 0.01% | 835.27x | 12.1x | 19.71x | 107.94x | 226.47x | 15.77B | ||
| -.--% | -.--% | -15.16x | 68.75x | 3987.56x | -18.51x | -15.84x | 14.03B | ||
| -.--% | -.--% | -450.97x | 18.43x | 32.38x | -2027.81x | -318.72x | 13.32B | ||
| -.--% | -.--% | 15.25x | 4.32x | 4.37x | 10.24x | 11.27x | 12.11B | ||
| -.--% | -.--% | -76.98x | 26.16x | 7.51x | -70.78x | -55.08x | 11.76B | ||
| -.--% | -.--% | -23.72x | 20x | 19.7x | -27.51x | -21.61x | 10.24B | ||
| -.--% | -.--% | -11.83x | -11x | 94.56x | -12.55x | -12.24x | 9.57B | ||
| -.--% | -.--% | 13.27x | 6.66x | 8.1x | 13.37x | 12.36x | 9.03B | ||
| 0.23% | 0.27% | 36.16x | 6.88x | 10.48x | 26.59x | 27.37x | 8.58B | ||
| -.--% | -.--% | -18.51x | 8.19x | 656.94x | -18.55x | -17.1x | 8.32B | ||
| Average | 0.11% | 0.14% | 13.79x | 13.96x | 288.42x | -118.74x | -9.47x | 17.03B | |
| Weighted average by Cap. | 0.28% | 0.34% | 26.67x | 13.38x | 223.60x | -87.63x | -1.11x |
- Stock Market
- Equities
- 2256 Stock
- Sector Abbisko Cayman Limited
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















